Apellis Pharmaceuticals, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Apellis Pharmaceuticals, Inc. Website Screenshot

http://www.apellis.com

Apellis Pharmaceuticals, Inc. Company Intro

Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.

Industry

Healthcare

Apellis Pharmaceuticals, Inc. Headquaters

6400 Westwind Way
Crestwood,40014
United States


Apellis Pharmaceuticals, Inc. Share price

28 Oct 2020 01:06 GMT

$34.13

-1.73 (-4.82 %)


Apellis Pharmaceuticals, Inc. Market cap

$2.686 B


WMC RANKING

2020

Apellis Pharmaceuticals, Inc. # 346

Biotechnology



Latest Apellis Pharmaceuticals, Inc. News

News 27 Oct 2020

Latham & Watkins Advises Sobi on Strategic Licensing and ...

Sobi, a specialised international biopharmaceutical company transforming the lives of people with rare diseases, and Apellis Pharmaceuticals, Inc., ...

News 27 Oct 2020

Cold Agglutinin Disease Market 2020-2027 Projected Huge Growth || Leading Players – Pfizer Inc, Novartis AG, Mylan NV, Teva Pharmaceuticals Industries Limited, Fresenius Kabi AG

... Pfizer Inc, Novartis AG, Mylan N.V., Teva Pharmaceuticals Industries Limited, ... Apellis Pharmaceuticals, Incyte Corporation, Johnson & Johnson Services Inc, ...

News 27 Oct 2020

Apellis and Sobi Enter Collaboration for Global Co ...

Apellis retains U.S. commercialization rights for systemic pegcetacoplan and ... Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Apellis Pharmaceuticals, Inc. 0 1.02 3.60 0 0 0 3.46
Alexion Pharmaceuticals, Inc. 100 13.31 100 20 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.32 26 0 0 97.51
3SBio Inc. 96.05 0 0 4 0 0 2.78
Incyte Corporation 40.27 14.26 7.19 100 0 0 90.89

Apellis Pharmaceuticals, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Apellis Pharmaceuticals, Inc. $0 $338,150 $-422,955 $2.686B 346
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.301B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $53.956B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.394B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.322B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Apellis Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors



Apellis Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries